References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Jungetal(2005)PharmacologicaleffectsofATI22-107[2-(2-{2-[2-chloro-4-(6-oxo-1,4,5,6-tetrahydro-pyridazin-3-yl)-phenoxy]-acetylamino}-ethoxymethyl)-4-(2-chloro-phenyl)-6-methyl-1,4-dihydro-pyridine-3,5-dicarboxylicaciddimethylester)],anoveldualpharmacophore,oJ.Pharmacol.Exp.Ther.312517PMID:15550574
PacherandStanek(1999)Ambulatoryvasodilatortherapyinheartfailure:systematicreviewoftheliteratureandpersonalobservationalexperience.Eur.J.HeartFail.1263PMID:10935673
Vroometal(1996)Effectofphosphodiesteraseinhibitorsonhumanarteriesinvitro.Br.J.Anaesth.76122PMID:8672353
Keywords:Enoximone,supplier,phosphodiesterases,pde3,pdeIII,inhibitors,inhibits,Phosphodiesterases,Phosphodiesterases,TocrisBioscience